Rapid disease progression after discontinuation of lenvatinib in thyroid cancer

Some thyroid cancer patients experience a rapid disease progression after the discontinuation of tyrosine kinase inhibitors (TKIs), which is called flare phenomenon. The incidence of the flare phenomenon of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) ranged from 4% to 11....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Medicine (Baltimore)
Main Authors: Yamazaki, Haruhiko, Sugino, Kiminori, Matsuzu, Kenichi, Masaki, Chie, Akaishi, Junko, Hames, Kiyomi, Tomoda, Chisato, Suzuki, Akifumi, Uruno, Takashi, Ohkuwa, Keiko, Kitagawa, Wataru, Nagahama, Mitsuji, Masuda, Munetaka, Ito, Koichi
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2020
Teme:
5700
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7220477/
https://ncbi.nlm.nih.gov/pubmed/32176066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019408
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki